Session Information
-
WCLC 2018
19th World Conference on Lung Cancer
Conference Program for the 19th World Conference on Lung Cancer in Toronto, Canada
Download PDF of the Abstract Book: Click Here.
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2391
September 23 Sun
Sep 23 Monday
September 24 Mon
Sep 24 Tuesday
September 25 Tue
Sep 25 Wednesday
September 26 Wed
Sep 26
-
+
PC06 - Controversies in Immunobiomarker Testing
- 13:30 - 15:00
- 9/25/2018
- Location: Room 106
- Type: Pro-Con Session
- Track: Pathology
-
+
PC06.01 - Laboratory Developed Test - PRO
13:30 - 13:50 | Presenter: Dara L. Aisner
- Abstract
No abstract available for this presentation
-
+
PC06.02 - Laboratory Developed Test - CON
13:50 - 14:10 | Presenter: Mari Mino-Kenudson
- Abstract
No abstract available for this presentation
-
+
PC06.03 - Tumor Mutation Burden - PRO
14:10 - 14:30 | Presenter: Lynette M Sholl
- Abstract
No abstract available for this presentation
-
+
PC06.04 - Tumor Mutation Burden - CON
14:30 - 14:50 | Presenter: Lukas Bubendorf
- Abstract
No abstract available for this presentation
-
+
PC06.05 - Q&A
14:50 - 15:00
- Abstract
No abstract available for this presentation
-
+
PC07 - The Future of Cytotoxic Chemotherapy in Advanced NSCLC
- 13:30 - 15:00
- 9/25/2018
- Location: Room 202 BD
- Type: Pro-Con Session
- Track: Advanced NSCLC
-
+
PC07.01 - Debate 2: Chemotherapy Will Become a Thing of the Past in the Management of Advanced NSCLC - For
14:10 - 14:30 | Presenter: Suresh S. Ramalingam
- Abstract
No abstract available for this presentation
-
+
PC07.02 - Debate 2: Chemotherapy Will Become a Thing of the Past in the Management of Advanced NSCLC - Against
14:30 - 14:50 | Presenter: Keunchil Park
- Abstract
No abstract available for this presentation
-
+
PC07.03 - Debate 1: For Wild-Type NSCLC, Which Will Be the Preferred Strategy: IO Alone versus Chemo + IO - IO Alone
13:30 - 13:50 | Presenter: Leora Horn
- Abstract
No abstract available for this presentation
-
+
PC07.04 - Debate 1: For Wild-Type NSCLC, Which Will Be the Preferred Strategy: IO Alone versus Chemo + IO - Chemo + IO
13:50 - 14:10 | Presenter: Federico Cappuzzo
- Abstract
No abstract available for this presentation
-
+
PC07.05 - Q&A
14:50 - 15:00
- Abstract
No abstract available for this presentation
-
+
PC08 - The Great Oligometastatic Debates
- 13:30 - 15:00
- 9/25/2018
- Location: Room 105
- Type: Pro-Con Session
- Track: Oligometastatic NSCLC
-
+
PC08.01 - Debate #1: Locally Ablative Therapies Should Be Standard Treatment for Patients with NSCLC Oligometastese (PRO)
13:30 - 13:40 | Presenter: Howard West
- Abstract
No abstract available for this presentation
-
+
PC08.02 - Debate #1: Locally Ablative Therapies Should Be Standard Treatment for Patients with NSCLC Oligometastese (CON)
13:40 - 13:50 | Presenter: Puneeth Iyengar
- Abstract
No abstract available for this presentation
-
+
PC08.03 - Discussion
13:50 - 14:00
- Abstract
No abstract available for this presentation
-
+
PC08.04 - Debate #2: Optimal Therapy for OM Disease: Thoracic Surgery Should Be the Treatment of Choice Whenever Possible
14:00 - 14:10 | Presenter: David R. Jones
- Abstract
No abstract available for this presentation
-
+
PC08.05 - Debate #2: Keep Calm and Beam On: Thoracic Radiation Obviates the Need for Surgery
14:10 - 14:20 | Presenter: Matthias Guckenberger
- Abstract
No abstract available for this presentation
-
+
PC08.06 - Discussion
14:20 - 14:30
- Abstract
No abstract available for this presentation
-
+
PC08.07 - Debate #3: Brain Metastases with a Driver Mutation Should Be Treated with Systemic Therapy First (PRO)
14:30 - 14:40 | Presenter: Mark K. Doherty
- Abstract
No abstract available for this presentation
-
+
PC08.08 - Debate #3: Brain Metastases with a Driver Mutation Should Be Treated with Systemic Therapy First (CON)
14:40 - 14:50 | Presenter: Marta Scorsetti
- Abstract
No abstract available for this presentation
-
+
PC08.09 - Discussion
14:50 - 15:00
- Abstract
No abstract available for this presentation
-
+
ES03 - How to Manage Pleural Plaques and Pleural Effusion with Negative Pleural Biopsy
- 15:15 - 16:45
- 9/25/2018
- Location: Room 206 AC
- Type: Educational Session
- Track: Mesothelioma
-
+
ES03.01 - Diagnosis of Mesothelioma Based on Cytology Alone
15:15 - 15:30 | Presenter: Jennifer Sauter
- Abstract
No abstract available for this presentation
-
+
ES03.02 - Role of CT Scan to Follow Pleural Plaques
15:30 - 15:45 | Presenter: Demetris Patsios
- Abstract
No abstract available for this presentation
-
+
ES03.03 - When to Repeat Pleural Biopsies
15:45 - 16:00 | Presenter: Catherine Labbe
- Abstract
No abstract available for this presentation
-
+
ES03.04 - Role of Chemotherapy in Mesothelioma with Minimal Bulk Disease
16:00 - 16:15 | Presenter: Christopher W. Lee
- Abstract
No abstract available for this presentation
-
+
ES03.05 - Role of Surgery in T0 Mesothelioma
16:15 - 16:30 | Presenter: Seiki Hasegawa | Author(s): Hiroshi Kodama, Masaki Hashimoto, Akihiro Fukuda, Toru Nakamichi, Akifumi Nakamura, Ayumi Kuroda, Teruhisa Takuwa, Seiji Matsumoto, Yoshitomo Okumura, Koichiro Yamakado, Takashi Kijima, Nobuyuki Kondo
- Abstract
No abstract available for this presentation
-
+
ES03.06 - Q&A
16:30 - 16:45
- Abstract
No abstract available for this presentation
-
+
ES04 - Liquid Biopsies in Lung Cancer
- 15:15 - 16:45
- 9/25/2018
- Location: Room 203 BD
- Type: Educational Session
- Track: Targeted Therapy
-
+
ES04.00 - Introduction with Poll Questions
15:15 - 15:20 | Presenter: Sai-Hong Ignatius Ou, Ignacio I. Wistuba
- Abstract
No abstract available for this presentation
-
+
ES04.01 - Liquid Biopsies in Lung Cancer
15:20 - 15:40 | Presenter: Ming Sound Tsao
- Abstract
No abstract available for this presentation
-
+
ES04.02 - Mechanisms of Resistance to Targeted Therapy
15:40 - 16:00 | Presenter: Christine Lovly
- Abstract
No abstract available for this presentation
-
+
ES04.03 - Overcoming Resistance by Improving Treatment Compliance
16:00 - 16:20 | Presenter: Felipe Gomes
- Abstract
No abstract available for this presentation
-
+
ES04.04 - Guiding Second Line Treatment in ALK + Patients (Sequence of Drugs, Rebiopsy?)
16:20 - 16:40 | Presenter: Enriqueta Felip
- Abstract
No abstract available for this presentation
-
+
ES04.05 - Q&A
16:40 - 16:45
- Abstract
No abstract available for this presentation
-
+
ES05 - Collaboration Between Stakeholders to Improve Lung Cancer Research
- 15:15 - 16:45
- 9/25/2018
- Location: Room 205 AC
- Type: Educational Session
- Track: Advocacy
-
+
ES05.01 - Linking the Stakeholders: Can Patient Groups, Clinical Researchers and the Pharmaceutical Industry Collaborate to Accelerate Research?
15:15 - 15:35 | Presenter: Janet Freeman-Daily
- Abstract
No abstract available for this presentation
-
+
ES05.02 - Can Patient Groups and Regulatory Bodies Work Together to Make Clinical Research Easier?
15:35 - 15:55 | Presenter: Andrea Ferris
- Abstract
No abstract available for this presentation
-
+
ES05.03 - Discrepancies and Sustainable Access to Innovative Therapies: Transforming Patient Experience in to Patient Voice
15:55 - 16:15 | Presenter: Jesme Fox
- Abstract
No abstract available for this presentation
-
+
ES05.04 - Challenges and Solutions in Engaging with the Health Technology Assessment Process in Canada
16:15 - 16:35 | Presenter: Christina Sit
- Abstract
No abstract available for this presentation
-
+
ES05.05 - Q&A
16:35 - 16:45
- Abstract
No abstract available for this presentation
-
+
GR02 - Management of N2 NSCLC - A Case Based Discussion
- 15:15 - 16:45
- 9/25/2018
- Location: Room 107
- Type: Grand Rounds Session
- Track: Treatment of Locoregional Disease - NSCLC
-
+
GR02.01 - Case 1: Single Zone N2 (No Pneumonectomy Necessary)
15:15 - 15:25 | Presenter: Anna Wrona
- Abstract
No abstract available for this presentation
-
+
GR02.02 - Panel Discussion
15:25 - 15:45 | Presenter: David Harpole, Hiroshi Date, Alexander Sun, Joop de Langen, Mary Duffy, Kathy S. Albain
- Abstract
No abstract available for this presentation
-
+
GR02.03 - Case 2: Multiple N2 Bulky Primary
15:45 - 15:55 | Presenter: Megan Eileen Daly
- Abstract
No abstract available for this presentation
-
+
GR02.04 - Panel Discussion
15:55 - 16:15 | Presenter: David Harpole, Hiroshi Date, Alexander Sun, Joop de Langen, Mary Duffy, Kathy S. Albain
- Abstract
No abstract available for this presentation
-
+
GR02.05 - Case 3: Post Operative Management of Incidentally Found N2 Disease
16:15 - 16:25 | Presenter: Masaya Yotsukura
- Abstract
No abstract available for this presentation
-
+
GR02.06 - Panel Discussion
16:25 - 16:45 | Presenter: David Harpole, Hiroshi Date, Alexander Sun, Joop de Langen, Mary Duffy, Kathy S. Albain
- Abstract
No abstract available for this presentation
-
+
MA19 - Genomic Markers of IO Response
- 15:15 - 16:45
- 9/25/2018
- Location: Room 201 BD
- Type: Mini Oral Abstract Session
- Track: Immunooncology
-
+
MA19.01 - Efficacy and Genomic Correlates of Response to Anti-PD1/PD-L1 Blockade in Non-Small Cell Lung Cancers Harboring Targetable Oncogenes
15:15 - 15:20 | Presenter: Natalie Vokes | Author(s): Elizabeth Jimenez Alguilar, Anika Adeni, Renato Umeton, Lynette M Sholl, Hira Rizvi, Matthew D. Hellmann, Mark M. Awad, Eliezer M. Van Allen
- Abstract
Loading... -
+
MA19.03 - Discussant - MA 19.01
15:20 - 15:35 | Presenter: Jonathan W. Goldman
- Abstract
No abstract available for this presentation
-
+
MA19.04 - The Clinical Implication of Frameshift Indel Mutation Burden in Non-Small Cell Lung Cancer (NSCLC)
15:35 - 15:40 | Presenter: Young Kwang Chae | Author(s): Wungki Park, Diana Saravia, Vaia Florou, Sangmin Chang, Si Wang, Lauren Chiec, Ashkon Alexander Rahbari, Nisha Mohindra, Victoria Villaflor, Lee Chun Park, Gilberto de Lima Lopes
- Abstract
Loading... -
+
MA19.05 - Difference of Tumor Mutational Burden Is Associated with Distinct Immune Microenviroment in the T Cell-Inflamed Lung Adenocarcinoma
15:40 - 15:45 | Presenter: Takahiro Karasaki | Author(s): Kentaro Kitano, Kazuhiro Nagayama, Jun-ichi Nitadori, Masaaki Sato, Masaki Anraku, Kazuhiro Kakimi, Jun Nakajima
- Abstract
Loading... -
+
MA19.06 - Blood Based Biomarkers: RNA, KRAS and PD-L1 Strongly Matching with Tissue and Showing Correlation with Clinical Responses In NSCLC Patient’s
15:45 - 15:50 | Presenter: Luis E Raez | Author(s): Joshua Usher, Cheryl Habaue, Kathleen Danenberg, Brian Hunis, Yolanda Jaimes, Shahrooz Rabizadeh, Aurelio Castrellon, Peter Danenberg
- Abstract
Loading... -
+
MA19.07 - Discussant - MA 19.04, MA 19.05, MA 19.06
15:50 - 16:05 | Presenter: Claudia Poleri
- Abstract
No abstract available for this presentation
-
+
MA19.08 - Detection of Primary Immunotherapy Resistance to PD-1 Checkpoint Inhibitors (PD1CI) in 2nd Line NSCLC
16:05 - 16:10 | Presenter: Joachim G.J.V. Aerts | Author(s): Egbert F Smit, Mirte Muller, Anna-Larissa Nadia Niemeijer, Carlos Oliveira, Heinrich Roder, Joanna Roder
- Abstract
Loading... -
+
MA19.09 - Concurrent Mutations in STK11 and KEAP1 is Associated with Resistance to PD-(L)1 Blockade in Patients with NSCLC Despite High TMB
16:10 - 16:15 | Presenter: Kathryn C Arbour | Author(s): Ronglai Shen, Andrew Plodkowski, Hira Rizvi, Ai Ni, Niamh Long, Darragh Halpenny, Francisco Sanchez-Vega, Charles M. Rudin, Gregory J Riely, Matthew D. Hellmann
- Abstract
Loading... -
+
MA19.10 - Impact of STK11/LKB1 Genomic Alterations on Clinical Outcomes with Chemo-Immunotherapy in Non-Squamous NSCLC
16:15 - 16:20 | Presenter: Ferdinandos Skoulidis | Author(s): Yasir Y Elamin, Vincent K Lam, Jianjun Zhang, Jeff Lewis, Waree Rinsurongkawong, Jack Lee, Jack A Roth, Stephen Swisher, Vassiliki A Papadimitrakopoulou, John V Heymach
- Abstract
Loading... -
+
MA19.11 - Discussant - MA 19.08, MA 19.09, MA 19.10
16:20 - 16:35 | Presenter: Lynette M Sholl
- Abstract
No abstract available for this presentation
-
+
MA19.12 - Q&A
16:35 - 16:45
- Abstract
No abstract available for this presentation
-
+
MA20 - Implementation of Lung Cancer Screening
- 15:15 - 16:45
- 9/25/2018
- Location: Room 206 F
- Type: Mini Oral Abstract Session
- Track: Screening and Early Detection
-
+
MA20.01 - Lung Cancer Screenee Selection by USPSTF versus PLCOm2012 Criteria – Preliminary ILST Findings
15:15 - 15:20 | Presenter: Martin Tammemägi | Author(s): Renelle L Myers, Mamta Ruparel, Niloofar Taghizadeh, Sukhinder Atkar-Khattra, Jennifer Dickson, Samantha Quaife, Angshu Bhowmik, Paul Burrowes, Paul Maceachern, Eric Bedard, John Yee, John Mayo, Jing Liu, Kwun M Fong, Alain Tremblay, Sam M Janes, Stephen Lam
- Abstract
Loading... -
+
MA20.02 - “Reduced” HUNT Lung Cancer Model for Predicting Lung Cancer in the Prospective Danish Lung Cancer Screening Study - Comparison with the NLST.
15:20 - 15:25 | Presenter: Oluf Dimitri Røe | Author(s): Maria Markaki, Ioannis Tsmardinos, Vincenzo Lagani, Jesper Holst Pedersen, Zaigham Saghir, Haseem Ashraf
- Abstract
Loading... -
+
MA20.03 - Surprising Implications of Proposed Risk-Thresholds for Selecting US Ever-Smokers into CT Lung-Cancer Screening
15:25 - 15:30 | Presenter: Hormuzd Katki | Author(s): Christine Berg, Anil Chaturvedi, Rebecca Landy, Hilary Robbins, Li C Cheung
- Abstract
Loading... -
+
MA20.04 - Discussant - MA 20.01, MA 20.02, MA 20.03
15:30 - 15:45 | Presenter: Amanda Tufman
- Abstract
No abstract available for this presentation
-
+
MA20.05 - Who Gets Screened for Lung Cancer? A Simple Adjustment to Current Guidelines to Reduce Racial Disparities
15:45 - 15:50 | Presenter: Melinda Aldrich | Author(s): Sarah Mercaldo, Kim L. Sandler, William J Blot, Eric Grogan, Jeffrey Blume
- Abstract
Loading... -
+
MA20.06 - Lung Cancer Screening Pilot for People at High Risk: Early Results on Cancer Detection and Staging
15:50 - 15:55 | Presenter: Martin Tammemägi | Author(s): Gail Elizabeth Darling, Heidi Schmidt, Monica Yu, Marianne Luettschwager, Bogdan Pylypenko, Tanvi Patel, Veronica Rivera, Katharine Pearson, Katie Larson
- Abstract
Loading... -
+
MA20.07 - Lung Cancer Screening for Limited-Resource Patients: Preliminary Findings from a Low-dose CT Pilot Program
15:55 - 16:00 | Presenter: Lesley Watson | Author(s): Megan May Cotter, Robert A. Smith, Katherine Sharpe
- Abstract
Loading... -
+
MA20.08 - Discussant - MA 20.05, MA 20.06, MA 20.07
16:00 - 16:15 | Presenter: Annette Maree McWilliams
- Abstract
No abstract available for this presentation
-
+
MA20.09 - Improved Lung Cancer and Mortality Prediction Accuracy Using Survival Models Based on Semi-Automatic CT Image Measurements
16:15 - 16:20 | Presenter: Anton Schreuder | Author(s): Colin Jacobs, Nikolas Lessmann, Ernst Scholten, Ivana Isgum, Mathias Prokop, Cornelia Schaefer-Prokop, Bram Van Ginneken
- Abstract
Loading... -
+
MA20.10 - Lung Cancer Prediction Using Deep Learning Software: Validation on Independent Multi-Centre Data
16:20 - 16:25 | Presenter: Peter Van Ooijen | Author(s): Heiko Peschl, Daiwei Han, Matthijs Oudkerk, Monique Dorrius, Mieneke Rook, Rozemarijn Vliegenthart, Claus Peter Heussel, Nadja Batora, Hans-Ulrich Kauczor, Carlos Da Silva, Oyunbileg Von Stackelberg, Roman Rubtsov, Mark Wielputz, Sarim Ather, Maria Tsakok, Carlos Arteta, Lyndsey Pickup, Samia Hussain, William Hickes, Petr Novotny, Catarina Santos, Emily Fay, Jerome Declerck, Vaclav Potesil, Timor Kadir, Fergus V Gleeson
- Abstract
Loading... -
+
MA20.12 - Discussant - MA 20.09, MA 20.10
16:25 - 16:40 | Presenter: Heidi Schmidt
- Abstract
No abstract available for this presentation
-
+
MA20.12a - Q&A
16:40 - 16:45
- Abstract
No abstract available for this presentation
-
+
MA21 - Molecular Subtyping, CBL3, and Non Coding RNA
- 15:15 - 16:45
- 9/25/2018
- Location: Room 205 BD
- Type: Mini Oral Abstract Session
- Track: Biology
-
+
MA21.01 - Cbl Mutations (mt) as Important Mediators of Oncogenic RTK Signaling in NSCLC
15:15 - 15:20 | Presenter: Rebecca Feldman | Author(s): Ari M. Vanderwalde, Stephen V Liu, Martin Frederik Dietrich, Shirish Gadgeel, Wolfgang M. Korn, Jorge Nieva, Alexander Spira, Edward S Kim
- Abstract
Loading... -
+
MA21.02 - Identification of an E2 Ubiquitin Conjugase CDC34 That Competes With E3 Ligase c-Cbl to Stabilize EGFR and Promotes Lung Carcinogenesis
15:20 - 15:25 | Presenter: Guangbiao Zhou | Author(s): Xin-Chun Zhao, Yun-Chao Huang
- Abstract
Loading... -
+
MA21.03 - Heterogeneity in MET Copy Number and Intratumoural Subsets in Pleomorphic Lung Carcinoma: Implications for MET Directed Therapy in NSCLC
15:25 - 15:30 | Presenter: Adam Januszewski | Author(s): Yu Zhi Zhang, Wei-Chin Chang, Ute Laggner, Alex Bowman, Toyin Adefila-Ideozu, William OC Cookson, Miriam F Moffatt, Andrew G Nicholson, Anne Bowcock, Sanjay Popat
- Abstract
Loading... -
+
MA21.04 - Discussant - MA 21.01, MA 21.02, MA 21.03
15:30 - 15:45 | Presenter: Ravi Salgia
- Abstract
No abstract available for this presentation
-
+
MA21.05 - Comprehensive Genomic Characterization and Prognostic Nomogram Developed by 295-Gene Panel Targeted Sequencing
15:45 - 15:50 | Presenter: Bin Zhang | Author(s): Lianmin Zhang, Tengfei Zhang, Dongsheng Yue, Chenguang Li, Zhenfa Zhang, Jun-Yi Ye, Hongming Wang, Shannon Chuai, Changli Wang
- Abstract
Loading... -
+
MA21.06 - Proteins Associated with Survival Differ Depending on Molecular Subtypes, and Mutational- and Smoking-Status In NSCLC Biopsies
15:50 - 15:55 | Presenter: Ann Rita Halvorsen | Author(s): Mads Haugland Haugen, Åsa Kristina Øjlert, Steinar Solberg, Lars Jørgensen, Gunhild M Mælandsmo, Odd Terje Brustugun, Åslaug Helland
- Abstract
Loading... -
+
MA21.07 - A Nation-Wide Population-Based Mapping of Targetable Alterations in Smoking-Independent Lung Cancer
15:55 - 16:00 | Presenter: Maria Planck | Author(s): Annette Salomonsson, Annika Patthey, Christel Reuterswärd, Mats Jönsson, Johan Botling, Hans Brunnström, Aziz Hussein, Nastaran Monsef, Cristian Ortiz-Villalon, Bengt Bergman, Luigi De Petris, Kristina Lamberg, Anders Vikström, Gunnar Wagenius, Annelie Behndig, Eva Brandén, Mikael Johansson, Hirsh Koyi, Johan Staaf
- Abstract
Loading... -
+
MA21.08 - Discussant - MA 21.05, MA 21.06, MA 21.07
16:00 - 16:15 | Presenter: Siddhartha Devarakonda
- Abstract
No abstract available for this presentation
-
+
MA21.09 - Differential Gene Expression in Tumor and Normal Tissue Reveals New Insights in the Biology of Non-Small Cell Lung Carcinoma.
16:15 - 16:20 | Presenter: Alan Spatz | Author(s): Vladimir Lazar, Eitan Rubin, Katherine D. Lach, Hangjun Wang, Andreas Papadakis, Roy Moscona, Patricia Jimenez, Goulnar Kasymjanova, Victor Cohen, Jason S Agulnik, Leon van Kempen
- Abstract
Loading... -
+
MA21.10 - Large-Scale Discovery of Novel Human Oncofetal Transcripts in Lung
16:20 - 16:25 | Presenter: Brenda C. Minatel | Author(s): Victor D Martinez, Adam P Sage, Erin A Marshall, Tomas Tokar, Daiana D. Becker-Santos, Wendy P. Robinson, Igor Jurisica, Wan Lam
- Abstract
Loading... -
+
MA21.11 - Epigenomic Mapping of Cell-Free DNA in Patients with Non-Small Cell Lung Cancer
16:25 - 16:30 | Presenter: Christine M Bestvina | Author(s): Jordan Karpus, Xiao-long Cui, Claire Oosterbaan, Brian Won, Chuan He, Jyoti Patel
- Abstract
Loading... -
+
MA21.12 - Discussant - MA 21.09, MA 21.10, MA 21.11
16:30 - 16:45 | Presenter: Geoffrey Liu
- Abstract
No abstract available for this presentation